Healthcare providers should counsel patients about these risks and redirect them toward proven therapies
As with any medication, adjusting to GLP-1 therapy can come with some side effects, particularly digestive issues like nausea, diarrhea, and constipation
Research on transdermal delivery of herbal extracts for metabolic effects is limited
Oral semaglutide contains an absorption enhancer called salcaprozate sodium, which helps the peptide survive the digestive tract and reach the bloodstream
These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist with a slightly different mechanism
10.1111/dom.12993 83 TwarogC.FattahS.HeadeJ.MaherS.FattalE.BraydenD